Foxp3 as a marker of tolerance induction versus rejection

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 40-45

  Zhang, Geoff Y ^a   Hu, Min ^a   Wang, Yuan Min ^a   Alexander, Stephen I ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Foxp3; Regulatory; Transplant tolerance

Indexed keywords

CD39 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CCR7; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 35; INTERLEUKIN 7 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHIMERA; CYTOKINE PRODUCTION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; VIRAL GENE DELIVERY SYSTEM; ADOPTIVE TRANSFER; ANIMAL; ANIMAL MODEL; DRUG EFFECT; GENETICS; GRAFT SURVIVAL; HELPER CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PREDICTION AND FORECASTING; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; BIOLOGICAL MARKERS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-17; MODELS, ANIMAL; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTS; TREATMENT OUTCOME;

EID: 67649173052     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32831da83c     Document Type: Review

References (76)

1. Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990; 171:141-157. (Pubitemid 20040605)
2. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
3. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061. (Pubitemid 36222930)
4. Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116:1713-1722. (Pubitemid 43911026)
5. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006; 103:6659-6664.
6. Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J Clin Invest 2003; 112:1310-1312. (Pubitemid 38057683)
7. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-1700. (Pubitemid 44036275)
8. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203:1701-1711. (Pubitemid 44036276)
9. Chen GY, Chen C, Wang L, et al. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 2008; 180:5163-5166.
10. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116:2423-2433.
11. Tone Y, Furuuchi K, Kojima Y, et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9:194-202.
12. Burchill MA, Yang J, Vang KB, et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008; 28:112-121.
13. Lio CW, Hsieh CS. A two-step process for thymic regulatory T cell development. Immunity 2008; 28:100-111.
14. Scotta C, Soligo M, Camperio C, Piccolella E. FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25-T lymphocytes. J Immunol 2008; 181:1025-1033.
15. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6:152-162. (Pubitemid 40268196)
16. Zheng Y, Josefowicz SZ, Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445:936-940. Identification of many of the gene targets of Foxp3. (Pubitemid 46309837)
17. Hu H, Djuretic I, Sundrud MS, Rao A. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol 2007; 28:329-332.
18. WuY, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006; 126:375-387. (Pubitemid 44092960)
19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
20. Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A 2007; 104:12099-12104. (Pubitemid 47185636)
21. YYang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29:44-56. Definition of the mechanisms that drive Tregs and Th17 development.
22. Kroemer A, Xiao X, Vu MD, et al. OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J Immunol 2007; 179:5584-5591.
23. Xiao X, Kroemer A, Gao W, et al. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo. J Immunol 2008; 181:3193-3201. Identification of the role of OX40 in limiting Tregs.
24. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13:1299-1307. (Pubitemid 350073591)
25. Ito T, Hanabuchi S, Wang YH, et al. Two functional subsets of FOXP3+ regulatory T cells in human thymusandperiphery. Immunity 2008; 28:870-880. Defines an IL-10 subset of Tregs using ICOS.
26. Zheng SG, Wang J, Horwitz DA. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 2008; 180:7112-7116. Suggests differences between adaptive and natural Tregs.
27. Maynard CL, Harrington LE, Janowski KM, et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 2007; 8:931-941.
28. Bayer AL, Lee JY, de la BA, et al. A function for IL-7R for CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 2008; 181:225-234.
29. de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34:2480-2488.
30. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:1142-1151. (Pubitemid 41541792)
31. Imamichi H, Sereti I, Lane HC. IL-15 acts as a potent inducer of CD4(+) CD25(hi) cells expressing FOXP3. Eur J Immunol 2008; 38:1621-1630.
32. Vang KB, Yang J, Mahmud SA, et al. IL-2, -7, and -15, but not thymic stromal lymphopoietin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol 2008; 181:3285-3290. All IL-2 family of cytokines can induce Foxp3.
33. Yamazaki S, Patel M, Harper A, et al. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A 2006; 103:2758-2763. (Pubitemid 43306622)
34. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-260. Role of retinoic acid in driving Foxp3 Tregs. (Pubitemid 47076203)
35. Gao W, Lu Y, El Essawy B, et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007; 7:1722-1732. (Pubitemid 46905432)
36. Chai JG, Xue SA, Coe D, et al. Regulatory T cells, derived from naive CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79:1310-1316. (Pubitemid 40734792)
37. Wang YM, Zhang GY, Wang Y, et al. Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 2006; 17:697-706.
38. Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Eur J Immunol 2008; 38:1381-1390.
39. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353:2342-2351. (Pubitemid 41713746)
40. Bunnag S, Allanach K, Jhangri GS, et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008; 8:1423-1433. (Pubitemid 351989494)
41. Bluestone JA, Liu W, Yabu JM, et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 2008; 8:2086-2096. Transient loss of Tregs in human transplant patients with anti-CD25 antibodies.
42. Bloom DD, Chang Z, Fechner JH, et al. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant 2008; 8:793-802. (Pubitemid 351347746)
43. Pascual J, Bloom D, Torrealba J, et al. Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells. Am J Transplant 2008; 8:1529-1536. (Pubitemid 351989487)
44. Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008; 111:453-462.
45. Basu S, Golovina T, Mikheeva T, et al. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 2008; 180:5794-5798. Mechanism for Treg expansion under sirolimus.
46. Bestard O, Cruzado JM, Mestre M, et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007; 179:4901-4909. Clinical demonstration of Treg function after transplant.
47. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358:353-361. Landmark study on renal transplantation tolerance through mixed chimerism. (Pubitemid 351159234)
48. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007; 17:94-97. Expansion of Tregs in tolerant liver patients. (Pubitemid 46240888)
49. Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4:2118-2125. (Pubitemid 39611642)
50. Bassuny WM, Ihara K, Sasaki Y, et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003; 55:149-156. (Pubitemid 36819361)
51. Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 2005; 102:5126-5131. (Pubitemid 40503750)
52. Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-341. (Pubitemid 40387475)
53. Lahl K, Loddenkemper C, Drouin C, et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007; 204:57-63. (Pubitemid 46148756)
54. Xu Q, Lee J, Jankowska-Gan E, et al. Human CD4+CD25 low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol 2007; 178:3983-3995. (Pubitemid 46417669)
55. Waldmann H, Adams E, Fairchild P, Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006; 212:301-313. (Pubitemid 44116716)
56. Waldmann H, Chen TC, Graca L, et al. Regulatory T cells in transplantation. Semin Immunol 2006; 18:111-119.
57. Graca L, Le Moine A, Cobbold SP, Waldmann H. Dominant transplantation tolerance. Curr Opin Immunol 2003; 15:499-506.
58. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195:1641-1646. (Pubitemid 34666077)
59. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14:88-92. Demonstration of the ability to induce tolerance in a major mismatch using Tregs.
60. Rubtsov YP, Rasmussen JP, Chi EY, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28:546-558.
61. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450:566-569.
62. Csencsits K, Wood SC, Lu G, Bishop DK. Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Am J Transplant 2005; 5:2378-2384. (Pubitemid 43919420)
63. Fu S, Zhang N, Yopp AC, et al. TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25- precursors. Am J Transplant 2004; 4:1614-1627. (Pubitemid 39312295)
64. Andersson J, Tran DQ, Pesu M, et al. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 2008; 205:1975-1981. Demonstration of the way in which Tregs induce infectious tolerance.
65. Daley SR, Ma J, Adams E, et al. A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts. J Immunol 2007; 179:3648-3654.
66. Pesu M, Watford WT, Wei L, et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 2008; 455:246-250.
67. Feng G, Gao W, Strom TB, et al. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3(+) regulatory T cells. Eur J Immunol 2008; 38:2512-2527.
68. Gondek DC, Lu LF, Quezada SA, et al. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:]1783-1786.
69. Sakaguchi S. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18-32. (Pubitemid 33070205)
70. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101:455-458.
71. Schnickel GT, Bastani S, Hsieh GR, et al. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. J Immunol 2008; 180:4714-4721. Chemokine regulation of Treg migration in transplants.
72. Menning A, Hopken UE, Siegmund K, et al. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol 2007; 37:1575-1583. (Pubitemid 46939492)
73. Lee I, Wang L, Wells AD, et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201:1037-1044. (Pubitemid 40524671)
74. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-1265. Important new pathway of Treg function. (Pubitemid 46919862)
75. Tsang JY, Tanriver Y, Jiang S, et al. Conferring indirect allospecificity on CD4CD25 Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008; 118:3619-3628. Analysis of indirect and direct allospecificity and their roles in limiting rejection.
76. Verma ND, Plain KM, Nomura M, et al. CD4+CD25+T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses. Blood 2008 [Epub ahead of print]. Potentially differing subsets of alloreactive Tregs driven by IL-2 or IL-4.